Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anneke Krol"'
Publikováno v:
Atherosclerosis, 218(2), 511-516. Elsevier Ireland Ltd
Atherosclerosis, 218(2), 511-6. Elsevier Ireland Ltd
Ujcic-Voortman, J K, Baan, C A, Verhoeff, A P, Krol, A & Seidell, J C 2011, ' Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. ', Atherosclerosis, vol. 218, no. 2, pp. 511-516 . https://doi.org/10.1016/j.atherosclerosis.2011.06.051
Ujcic-Voortman, J K, Baan, C A, Verhoeff, A P, Krol, A & Seidell, J C 2011, ' Ethnic differences in systemic inflammation : an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands ', Atherosclerosis, vol. 218, no. 2, pp. 511-6 . https://doi.org/10.1016/j.atherosclerosis.2011.06.051
Atherosclerosis, 218(2), 511-6. Elsevier Ireland Ltd
Ujcic-Voortman, J K, Baan, C A, Verhoeff, A P, Krol, A & Seidell, J C 2011, ' Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. ', Atherosclerosis, vol. 218, no. 2, pp. 511-516 . https://doi.org/10.1016/j.atherosclerosis.2011.06.051
Ujcic-Voortman, J K, Baan, C A, Verhoeff, A P, Krol, A & Seidell, J C 2011, ' Ethnic differences in systemic inflammation : an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands ', Atherosclerosis, vol. 218, no. 2, pp. 511-6 . https://doi.org/10.1016/j.atherosclerosis.2011.06.051
OBJECTIVE: C-reactive protein (CRP) is a sensitive, non-specific systemic marker for inflammation and tissue damage in the human body and independently associated with incident cardiovascular disease (CVD) and traditional CVD risk factors. The aim of
Publikováno v:
Quality of life research, 17(7), 1021-1029. Springer Netherlands
AIMS: To confirm the factorial structure of the Short Form 36 Health Survey (SF-36) in problem drug users and to compare their health-related quality of life (HRQOL) with general Dutch population norms. METHOD: Data of 394 participants from the Amste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6943f32f401c7070c67c1d610bb8ed3b
https://pure.amc.nl/en/publications/an-assessment-of-factorial-structure-and-healthrelated-quality-of-life-in-problem-drug-users-using-the-short-form-36-health-survey(f98b4c23-5a2c-463e-8081-ba9fbfc9385f).html
https://pure.amc.nl/en/publications/an-assessment-of-factorial-structure-and-healthrelated-quality-of-life-in-problem-drug-users-using-the-short-form-36-health-survey(f98b4c23-5a2c-463e-8081-ba9fbfc9385f).html
Autor:
Pia S, Kivelä, Anneke, Krol, Mika O, Salminen, Ronald B, Geskus, Jukka I, Suni, Veli-Jukka, Anttila, Kirsi, Liitsola, Veera, Zetterberg, Frank, Miedema, Ben, Berkhout, Roel A, Coutinho, Matti A, Ristola
Publikováno v:
Scandinavian journal of infectious diseases. 37(4)
An explosive outbreak of HIV-1 caused by the recombinant subtype AE (CRF01-AE) was detected in 1998 among Finnish injecting drug users (IDUs). These IDUs were compared with IDUs from the Amsterdam Cohort Study (ACS) infected with subtype B, to detect
Publikováno v:
European Journal of Epidemiology; Jun2006, Vol. 21 Issue 6, p469-473, 5p